Filing metadata

Accession number
0001209191-22-061093
Form type
Form 4
Filer
Anebulo Pharmaceuticals, Inc.
CIK
CIK 1815974
Filed
Dec 13, 2022
Reporting period
Dec 09, 2022
Description
Insider transaction

Explore SEC Filings Hub